CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
A phase 1b study to assess the combination of ARV-471 and everolimus in participants with advanced or metastatic ER+/HER2- breast cancer...
Phase 1
San Diego, California, United States and 8 other locations
This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their ...
Phase 3
San Diego, California, United States and 226 other locations
A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....
Phase 3
Encinitas, California, United States and 324 other locations
Most physicians still use a one-size-fits-all approach to breast screening in which all women, regardless of their personal history, family ...
San Diego, California, United States and 10 other locations
The purpose of this study will be to evaluate, in a multi-center setting, the ability of radiofrequency ablation (RFA) of breast cancer...
San Diego, California, United States and 5 other locations
Some human epidermal growth factor receptor 2 (HER-2) breast cancer patients do not respond or become resistant to current treatmen...
Phase 2
San Diego, California, United States and 98 other locations
OKI-219-101 is a Phase 1a/1b, open-label, multicenter, dose-escalation study designed to evaluate the safety, tolerability, pharmacokinetics (PK), ph...
Phase 1
Encinitas, California, United States and 8 other locations
of phosphoinositide-3-kinase (PI3K)-gamma, in combinations with Tecentriq and Abraxane (nab-paclitaxel) in front-line triple negative breast...
Phase 2
San Diego, California, United States and 23 other locations
versus T-DM1 in HER2-positive, unresectable and/or metastatic breast cancer subjects previously treated with trastuzumab and taxane....
Phase 3
San Diego, California, United States and 163 other locations
Patients with HER2-positive primary breast cancer (BC) who do not achieve complete response after appropriate neoadjuvant therapy a...
Phase 3
San Diego, California, United States and 482 other locations
Clinical trials
Research sites
Resources
Legal